
Bayer and MOMA Therapeutics Form Collaborative Licensing Agreement in Oncology
Bayer and MOMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing a new generation of precision therapeutics, have announced a collaboration through an option and exclusive license agreement. This partnership aims to develop and commercialize a small molecule oncology…